✦ LIBER ✦

Cost-Effectiveness Analysis of Ziprasidone versus Haloperidol in Sequential Intramuscular/Oral Treatment of Exacerbation of Schizophrenia

✍ Scribed by Fernando Cañas, Víctor Pérez-Solá, Silvia Díaz, Dr Javier Rejas

Book ID: 119930202
Publisher: Springer International Publishing AG
Year: 2007
Tongue: English
Weight: 180 KB
Volume: 27
Category: Article
ISSN: 1179-1918
DOI: 10.2165/00044011-200727090-00005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ziprasidone vs haloperidol in sequential

Ziprasidone vs haloperidol in sequential IM/oral treatment of acute schizophrenia

✍ S. Brook 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 155 KB

PMH28 COST-EFFECTIVENESS ANALYSIS OF ZIP

PMH28 COST-EFFECTIVENESS ANALYSIS OF ZIPRASIDONE VERSUS NO TREATMENT FOR SCHIZOPHRENIA RELAPSE PREVENTION

✍ JR Azanza; M Bernardo; C Rubio-Terrés; V Diez; J Rejas 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

PMH21 Cost-Effectiveness of Intramuscula

PMH21 Cost-Effectiveness of Intramuscular Ziprasidone for the Treatment of Acute Agitation Associated to Schizophrenia in Mexico

✍ R.M. Galindo-Suárez; G. Peniche-Otero; J. Herrera-Rojas; G. Baeza-Cruz; A. Nencl 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Comparative efficacy and tolerability of

Comparative efficacy and tolerability of intramuscular/oral ziprasidone versus haloperidol: Clinical findings in Asian and foreign patients with acute schizophrenia

✍ B. Parsons; C. Siu; G. Cohen 📂 Article 📅 2008 🏛 Elsevier Science 🌐 French ⚖ 44 KB

Ziprasidone and haloperidol in the treat

Ziprasidone and haloperidol in the treatment of acute exacerbation of schizophrenia and schizoaffective disorder: comparison of intramuscular and oral formulations in a 6-week, randomized, blinded-assessment study

✍ Shlomo Brook; Jeorg Walden; Isma Benattia; Cynthia O. Siu; Steven J. Romano 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 189 KB

A pilot study of intramuscular ziprasido

A pilot study of intramuscular ziprasidone in the short-term treatment of patients with acute exacerbation of schizophrenia

✍ Shlomo Brook 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB 👁 2 views

Ziprasidone is a novel antipsychotic which, in oral formulation, has been shown to be effective and well tolerated in the treatment of acute psychosis. This pilot study examined the efficacy and tolerability of the intramuscular (IM) formulation and the transition from IM to oral ziprasidone in pati